二味康口服液对动物体内部分球蛋白的影响

来源 :同济医科大学学报 | 被引量 : 0次 | 上传用户:wjln123456
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
肿瘤及免疫抑制剂均可导致免疫力低下 ,表现为免疫球蛋白 Ig G、 Ig M等水平降低。二味康口服液用于治疗由肺瘤及环磷酰胺引起的免疫球蛋白减少的小鼠 ,结果表明 ,治疗 15 d后 ,低下的 Ig G及 Ig M水平明显升高 (P<0 .0 5 ,0 .0 1)。正常大鼠大剂量服用该药后 ,亦可见球蛋白水平升高。实验结果提示 ,二味康口服液能增强免疫功能且通过该作用达到治疗肿瘤及免疫力低下引起的其他疾病 ,并能增强机体抗病能力 Tumors and immunosuppressive agents can lead to low immunity, manifested as immunoglobulin Ig G, Ig M and other levels decreased. Erwei Kang oral solution for the treatment of lung cancer and cyclophosphamide-induced immunoglobulin reduction in mice, the results showed that 15 d after treatment, low Ig G and Ig M levels were significantly increased (P <0 .0 5, 0 .0 1). Normal rats after taking the high-dose medicine, also showed elevated globulin levels. The experimental results suggest that Erwei Kang oral liquid can enhance the immune function and achieve the treatment of tumors and other diseases caused by low immunity through the effect and can enhance the body’s resistance to diseases
其他文献